Conductive nanocomposite hydrogel and mesenchymal stem cells for the treatment of myocardial infarction and non-invasive monitoring via PET/CT.

J Nanobiotechnology · 2022 · PMC9077894 · PMID 35524274

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Subsequently, as the protective effect could not last long, apoptosis of myocardial cells in ischemic myocardium continued to occur, the non-viable myocardium area showed a trend of continuous expansion except MSC/GNR@SN/Gel group.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.